Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Participants involved in these trials were also advised to take a low calorie diet and exercise, showing the need to take semaglutide alongside other measures. When compared to the placebo groups ...

Pro Tip Popular weight loss drugs, such as GLP-1 semaglutide injections Wegovy and Ozempic, are often on the Food and Drug Administration (FDA) drug shortage list. This allows some companies to ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.

Identifying 'Stealth' Sources of Saturated Fat, Added Sugar in the Diet Aug. 15, 2024 — A newly compiled list of foods and drinks commonly consumed in the United States hints at why many adults ...

On August 8, 2024, the US Food and Drug Administration (FDA) partially revised the availability of certain glucagon-like peptide 1 (GLP-1) ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...